Sign in to use this feature.

Years

Between: -

Subjects

remove_circle_outline
remove_circle_outline

Journals

Article Types

Countries / Regions

Search Results (1)

Search Parameters:
Keywords = hard metal lung disease

Order results
Result details
Results per page
Select all
Export citation of selected articles as:
18 pages, 294 KB  
Review
Beyond the Graft: Recurrence of Interstitial Lung Diseases Post Transplant
by Prince Ntiamoah and Atul C. Mehta
J. Clin. Med. 2025, 14(4), 1093; https://doi.org/10.3390/jcm14041093 - 8 Feb 2025
Cited by 1 | Viewed by 1070
Abstract
Interstitial lung diseases (ILDs) represent a heterogenous group of lung disorders marked by inflammation and/or fibrosis of the lung parenchyma, often leading to progressive shortness of breath and end-stage respiratory failure. In the U.S., ILDs affect approximately 650,000 individuals and cause approximately 25,000–30,000 [...] Read more.
Interstitial lung diseases (ILDs) represent a heterogenous group of lung disorders marked by inflammation and/or fibrosis of the lung parenchyma, often leading to progressive shortness of breath and end-stage respiratory failure. In the U.S., ILDs affect approximately 650,000 individuals and cause approximately 25,000–30,000 deaths annually. Lung transplantation (LTx) offers definitive treatment for advanced ILD, with improved survival attributed to advancements in immunosuppression, organ preservation, surgical techniques, and postoperative care. However, disease recurrence in transplanted lungs remains a significant concern. Understanding the risk factors and mechanisms underlying recurrence is critical for refining recipient selection and improving outcomes. This review examines ILD recurrence post LTx and its implications for lung transplantation success. Full article
(This article belongs to the Special Issue Updates on Interstitial Lung Disease)
Back to TopTop